Getein Biotech Inc - Asset Resilience Ratio

Latest as of March 2026: 29.77%

Getein Biotech Inc (603387) has an Asset Resilience Ratio of 29.77% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥1.10 Billion

≈ $161.12 Million USD Cash + Short-term Investments

Total Assets

CN¥3.70 Billion

≈ $541.26 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Getein Biotech Inc's Asset Resilience Ratio has changed over time. Check Getein Biotech Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Getein Biotech Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Getein Biotech Inc.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.10 Billion	29.77%
Total Liquid Assets	CN¥1.10 Billion	29.77%

Asset Resilience Insights

Very High Liquidity: Getein Biotech Inc maintains exceptional liquid asset reserves at 29.77% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Getein Biotech Inc Industry Peers by Asset Resilience Ratio

Compare Getein Biotech Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Sinocare Inc SHE:300298	Medical Devices	3.53%
T&R Biofab Co. Ltd KQ:246710	Medical Devices	0.12%
Diagnostic Medical Systems SA PA:ALDMS	Medical Devices	1.48%
Pulsenmore Ltd. Ordinary Shares NASDAQ:PLSM	Medical Devices	46.67%
Allmed Solutions Ltd TA:ALMD	Medical Devices	80.03%
Universal Biosensors Inc AU:UBI	Medical Devices	14.72%
EBR Systems Inc AU:EBR	Medical Devices	54.70%
Cochlear Ltd AU:COH	Medical Devices	9.76%

Annual Asset Resilience Ratio for Getein Biotech Inc (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Getein Biotech Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	24.30%	CN¥912.63 Million ≈ $133.55 Million	CN¥3.76 Billion ≈ $549.61 Million	+6.80pp
2024-12-31	17.50%	CN¥648.88 Million ≈ $94.95 Million	CN¥3.71 Billion ≈ $542.51 Million	+5.52pp
2023-12-31	11.98%	CN¥451.91 Million ≈ $66.13 Million	CN¥3.77 Billion ≈ $551.91 Million	-1.92pp
2022-12-31	13.90%	CN¥511.14 Million ≈ $74.80 Million	CN¥3.68 Billion ≈ $538.12 Million	-5.63pp
2021-12-31	19.52%	CN¥612.68 Million ≈ $89.65 Million	CN¥3.14 Billion ≈ $459.18 Million	-2.51pp
2020-12-31	22.03%	CN¥594.92 Million ≈ $87.06 Million	CN¥2.70 Billion ≈ $395.09 Million	-1.24pp
2019-12-31	23.28%	CN¥467.36 Million ≈ $68.39 Million	CN¥2.01 Billion ≈ $293.78 Million	-26.79pp
2017-12-31	50.07%	CN¥634.14 Million ≈ $92.79 Million	CN¥1.27 Billion ≈ $185.34 Million	+11.58pp
2016-12-31	38.49%	CN¥167.08 Million ≈ $24.45 Million	CN¥434.09 Million ≈ $63.52 Million	--

pp = percentage points

About Getein Biotech Inc

SHG:603387 China Medical Devices

Market Cap

$665.69 Million

CN¥4.55 Billion CNY

Market Cap Rank

#10790 Global

#2941 in China

Share Price

CN¥8.97

Change (1 day)

+0.79%

52-Week Range

CN¥7.52 - CN¥10.65

All Time High

CN¥21.49